(Q83477431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21351813%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Aztreonam lysine for inhalation solution in cystic fibrosis: profile report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21351813%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

1 reference

Greg L Plosker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21351813%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21351813%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21351813%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21351813%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21351813%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

129-131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21351813%20AND%20SRC:MED&resulttype=core&format=json

Tissue injury caused by deposition of immune complexes is L-arginine dependent

23 January 2020

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Aerosol antibiotics in cystic fibrosis.

1 reference

12 December 2020

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

1 reference

12 December 2020

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis

1 reference

12 December 2020

Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis

1 reference

12 December 2020

1 reference

12 December 2020

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

1 reference

12 December 2020

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

1 reference

12 December 2020

1 reference

12 December 2020

An 18‐month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

1 reference

12 December 2020

Nebulized antibiotics in cystic fibrosis

1 reference

12 December 2020

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

1 reference

12 December 2020

Administration of aerosolized antibiotics in cystic fibrosis patients

1 reference

12 December 2020

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

12 December 2020

Aerosol treatment of cystic fibrosis

1 reference

12 December 2020

Inhaled antibiotics in cystic fibrosis

1 reference

12 December 2020

Antibiotic treatment. Aerosol therapy

1 reference

12 December 2020

Aztreonam lysine for inhalation solution: in cystic fibrosis

1 reference

12 December 2020

Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis

1 reference

12 December 2020

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

1 reference

12 December 2020

Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis

1 reference

12 December 2020

Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis

1 reference

12 December 2020

Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride)

1 reference

12 December 2020

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

12 December 2020

A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.

1 reference

12 December 2020